Tislelizumab Combined With Chemotherapy and Thoracic Radiotherapy in ES-SCLC

NCT06536868 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: Tislelizumab
DRUG: Etoposide
DRUG: Carboplatin or Cisplatin
RADIATION: Thoracic radiotherapy

Sponsor

Second Hospital of Shanxi Medical University